SCHEMBL28462913

SCHEMBL28462913

NC(CC(=O)O)C(=O)C(N)(CO)C(=O)O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRR1 P24046 2/20 0.31
LMNA P02545 1/20 0.31
SLC22A6 Q4U2R8 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HIF1A Q16665 1/20 0.31
GRM8 O00222 1/20 0.30
GRM6 O15303 1/20 0.30
GRIN2D O15399 1/20 0.30
GRIN3B O60391 1/20 0.30
GSR P00390 1/20 0.30
CYP1A2 P05177 1/20 0.30
GRIK1 P39086 1/20 0.30
GRM5 P41594 1/20 0.30
GRIA1 P42261 1/20 0.30
GRIA2 P42262 1/20 0.30
GRIA3 P42263 1/20 0.30
SLC1A3 P43003 1/20 0.30
SLC1A2 P43004 1/20 0.30
SLC1A1 P43005 1/20 0.30
GRIA4 P48058 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7757143 0.82 MEN1 (0.37) GABRR1LMNASLC22A6CYP1A2GRIK1
SCHEMBL3783637 0.79 GRM2 (0.36) GRIK1SLC1A3SLC1A2SLC1A1GRM2
SCHEMBL3783644 0.79 GRM2 (0.36) GRIK1SLC1A3SLC1A2SLC1A1GRM2
SCHEMBL5582239 0.78 KMT2A (0.37) GRM8GRM6GRIN2DGRIN3BGSR
SCHEMBL10509551 0.77 SLC22A6 (0.35) GABRR1LMNASLC22A6SMN1; SMN2GRM8
SCHEMBL10508640 0.77 SLC22A6 (0.35) GABRR1LMNASLC22A6SMN1; SMN2GRM8
SCHEMBL27422541 0.77 SLC22A6 (0.35) GABRR1LMNASLC22A6SMN1; SMN2GRM8
SCHEMBL5658804 0.74 SMN1; SMN2 (0.64) SMN1; SMN2HIF1ASLC1A3SLC1A2SLC1A1
SCHEMBL2807597 0.73 GRIK1 (0.35) GABRR1LMNASLC22A6HIF1AGRIK1
SCHEMBL7754149 0.73 GRIK1 (0.35) GABRR1LMNASLC22A6HIF1AGRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107108744-B anti-CD 123 Chimeric Antigen Receptor (CAR) for cancer therapy 诺华股份有限公司 2020-09-25 CN disclosed